Cargando…
Presepsin Predicts Severity and Secondary Bacterial Infection in COVID-19 by Bioinformatics Analysis
INTRODUCTION: Novel coronavirus pneumonia (COVID-19) is an acute respiratory disease caused by the novel coronavirus SARS-CoV-2. Severe and critical illness, especially secondary bacterial infection (SBI) cases, accounts for the vast majority of COVID-19-related deaths. However, the relevant biologi...
Autores principales: | Chang, Yufei, Liu, Linan, Wang, Hui, Liu, Jinghe, Liu, Yuwei, Du, Chunjing, Hua, Mingxi, Liu, Xinzhe, Liu, Jingyuan, Li, Ang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470340/ https://www.ncbi.nlm.nih.gov/pubmed/36110569 http://dx.doi.org/10.1155/2022/9914927 |
Ejemplares similares
-
Bacterial and fungal co-infections among COVID-19 patients in intensive care unit
por: Yang, Siyuan, et al.
Publicado: (2021) -
The novel outer membrane protein from OprD/Occ family is associated with hypervirulence of carbapenem resistant Acinetobacter baumannii ST2/KL22
por: Hua, Mingxi, et al.
Publicado: (2020) -
Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID-19
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2023) -
Presepsin (Scd14) as a Marker of Serious Bacterial Infections in Chemotherapy Induced Severe Neutropenia
por: Olad, Elham, et al.
Publicado: (2014) -
Predictive value of presepsin and acylcarnitines for severity and biliary drainage in acute cholangitis
por: Zhang, Han-Yu, et al.
Publicado: (2023)